[Immunomodulatory actions of antibiotics]. 2009

Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
Specijalisticka ordinacija "Dr Bojić", Beograd.

BACKGROUND Antimicrob drugs and immune system interaction has been studied since the pioneer works of Metchnikoff. After the introduction of antibiotics in clinical practice this area has attracted little attention of investigators, because of the lack of standards. This is the reason that the studying of the influence of antibiotics on immune system is still at its beginning. OBJECTIVE To point out the immunomodulatory action of some antibiotics on certain components of immune system. RESULTS The literature findings show that antibiotics express immunomodulatory action on some components of immune system such as fagocytes (polymorphonucleary, macrophages, monocytes), cytokines, immunoglobulines, and on cellular immunity. The principles of antibiotics action on phagocyte are the inhibition of chemotaxis and oxidants production. Macrolides applied for a short time enhance the phagocytic functions while their long use leads to immunosupression. Some cephalosporines and rifampicin in therapeutic doses inhibit the oxydative metabolism, of macrophages. Tetracyclines, clindamycines, chloramphenicol and tobramycin inhibit the synthesis of superoxyd anione. The action of some antibiotics on cytokine and specific antibodies is also important. Cellular immunity can be affected as well. After administration of certain antibiotics it takes 1-2 weeks to reestablish normal cellular immunity, and for other even more. CONCLUSIONS There is still no clear standing on real effects of antibiotics on the immune system. Clinicians should search for more information from this new-old field of investigation in order to give more adequate therapy to patients.

UI MeSH Term Description Entries
D007107 Immune System The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components. Immune Systems,System, Immune,Systems, Immune
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010586 Phagocytes Cells that can carry out the process of PHAGOCYTOSIS. Phagocyte,Phagocytic Cell,Phagocytic Cells,Cell, Phagocytic,Cells, Phagocytic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
August 2002, Molecular and cellular endocrinology,
Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
January 2008, Current molecular pharmacology,
Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
June 1995, The Journal of steroid biochemistry and molecular biology,
Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
August 1997, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
March 1957, Medical world,
Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
April 2017, Biophysical reviews,
Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
January 1997, Expert opinion on investigational drugs,
Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
March 2003, Current medicinal chemistry,
Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
January 2014, Acta reumatologica portuguesa,
Svetlana Minić, and Milena Bojić, and Jovan Vukadinov, and Grozdana Canak, and Milotka Fabri, and Ivanko Bojić
July 2020, Cancers,
Copied contents to your clipboard!